Regulatory controversy surrounding ipecac use and misuse
Brushwood, D.B.; Tietze, K.J.
American Journal of Hospital Pharmacy 43(1): 157-161
1986
ISSN/ISBN: 0002-9289 PMID: 2869686 Document Number: 276732
Document emailed within 1 workday
Related Documents
Klotz, L. 2016: Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer Oncology 30(8): 694; 764Klitsch, M. 1993: Injectable hormones and regulatory controversy: an end to the long-running story? Family Planning Perspectives 25(1): 37-40
Cooper, C.; Kilham, H.; Ryan, M. 1998: Ipecac--a substance of abuse Medical Journal of Australia 168(2): 94-95
Mofenson, H.C.; Caraccio, T.R. 1986: Benefits/risks of syrup of ipecac Pediatrics 77(4): 551-552
Yamashita, M.; Yamashita, M.; Fujii, Y. 2001: Pharmacokinetics and tissue distribution of ipecac syrup Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 14(1): 11-15
Smith, E.; Sharkey, M.F.; Levine, J. 1971: Assay of ipecac and its preparations. I. Development of the method Journal - Association of Official Analytical Chemists 54(3): 609-613
Cerný, M. 1971: Syrup with ipecac- asuitable emetic for poisoning in children Ceskoslovenska Pediatrie 26(12): 595
Krenzelok, E.P.; Dean, B.S. 1987: Effectiveness of 15-mL versus 30-mL doses of syrup of ipecac in children Clinical Pharmacy 6(9): 715-717
Nakanishi, H.; Takai, Y. 2001: Regulatory mechanism of neurotransmitter release by low-molecular-weight G protein, Rab3A and the regulatory proteins Masui. Japanese Journal of Anesthesiology 50 Suppl: S51-S55
Schneider, D.J.; Perez, A.; Knilans, T.E.; Daniels, S.R.; Bove, K.E.; Bonnell, H. 1996: Clinical and pathologic aspects of cardiomyopathy from ipecac administration in Munchausen's syndrome by proxy Pediatrics 97(6 Part 1): 902-906
Frank, R.J.; Bianchi, R.J.; Barnes, W.H. 1989: Cooperative regional program for distribution of poison prevention information and syrup of ipecac American Journal of Hospital Pharmacy 46(4): 719-723
Holguin, M.H.; Martin, C.B.; Eggett, T.; Parker, C.J. 1996: Analysis of the gene that encodes the complement regulatory protein, membrane inhibitor of reactive lysis (CD59). Identification of an alternatively spliced exon and characterization of the transcriptional regulatory regions of the promoter Journal of Immunology 157(4): 1659-1668
Friborg, Søren. 2003: Misuse of the DSAM name Ugeskrift for Laeger 165(41): 3940; Author Reply 3940
Elsborg, L. 1979: Use and misuse of vitamin C Nordisk Medicin 94(11): 299-300
Graham, M.A. 1988: Misuse of midazolam Journal of Clinical Psychiatry 49(6): 244
Mathur, G.P.; Kushwaha, K.P.; Prakash, O. 1986: Misuse of steroids Indian Pediatrics 23(9): 713-718
Chan-Chee, C.; De Vincenzi, I.; Sole-Pla, M.A.; Ancelle-Park, R.; Brunet, J.B. 1991: Use and misuse of condoms Genitourinary Medicine 67(2): 173
Fazio, A. 1990: Misuse of Digibind is costly American Journal of Hospital Pharmacy 47(11): 2460
Bull, M.J.; Stroup, K.B.; Gerhart, S. 1988: Misuse of car safety seats Pediatrics 81(1): 98-101
Salamah, S.D.; Hossain, M.M.; Ahmed, T. 2000: Enquiry into the causes of misuse of antibiotics Saudi Medical Journal 21(10): 986-987